In addition, two interesting observations were made during the study: firstly; treatment withdrawal caused tumor reoccurrence compared to continuously-treated mice, hence confirming the treatment effect; and secondly, an induction of retinoic acid receptor β2 (RARβ2) was observed, suggesting that HDAC inhibitors might reverse retinoid resistance. Here, HDAC9 is linked to neoplasm.